Metronidazole Benzoate
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C13H13N3O4 275.26
2-(2-Methyl-5-nitroimidazol-1-yl)ethyl benzoate CAS RN®: 13182-89-3; UNII: A355C835XC.
1 DEFINITION
Metronidazole Benzoate contains NLT 98.5% and NMT 101.0% of metronidazole benzoate (C13H13N3O4), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. ▲SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K ▲(CN 1-MAY-2020)
B. The principal spot of the Sample solution corresponds to that of Standard solution A, as obtained in the test for Organic Impurities.
3 ASSAY
PROCEDURE
Sample solution: Dissolve with stirring 250 mg of Metronidazole Benzoate in 50.0 mL of glacial acetic acid.
Titrimetric system
(See Titrimetry (541).)
Mode: Direct titration
Titrant: 0.1 N perchloric acid
Endpoint detection: Potentiometric
Analysis: Titrate the Sample solution with Titrant. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 27.53 mg of 13 13 (C13H13N3O4).
Acceptance criteria: 98.5%-101.0% on the dried basis
4 IMPURITIES
4.1 RESIDUE ON IGNITION (281)
NMT 0.1%
4.2 ORGANIC IMPURITIES
Standard solution A: 0.1 mg/mL of USP Metronidazole Benzoate RS in acetone
Standard solution B: 0.04 mg/mL of USP Metronidazole Benzoate RS in acetone from Standard solution A
Standard solution C: 0.2 mg/mL each of USP Metronidazole RS and USP Tinidazole Related Compound A RS in acetone
Sample solution: 20 mg/mL of Metronidazole Benzoate in acetone
Chromatographic system
(See Chromatography (621), Thin-Layer Chromatography.)
Mode: TLC
Adsorbent: 0.2-mm layer of chromatographic silica gel mixture
Application volume: 10 µL
Developing solvent system: Ethyl acetate
System suitability
Sample: Standard solution C
Suitability requirements: The test is valid only if the metronidazole and tinidazole related compound A spots are clearly separated.
Analysis
Samples: Standard solution A, Standard solution B, Standard solution C, and Sample solution
Proceed as directed in the chapter. Examine the plate under short-wavelength UV light.
Acceptance criteria: No secondary spot of the Sample solution is larger or more intense than the principal spot of Standard solution A (0.5%); and NMT three spots, excluding the principal spot, of the Sample solution are larger or more intense than the principal spot of Standard solution B (0.2%).
5 SPECIFIC TESTS
5.1 ACIDITY
Sample: 2.0 g
Analysis: Neutralize 40 mL of a mixture of dimethylformamide and water (1:1) with hydrochloric acid or 0.02 M sodium hydroxide. Add 0.2 mL of methyl red TS and the Sample, mix to dissolve, and titrate with 0.02 M sodium hydroxide.
Acceptance criteria: NMT 0.25 mL is required to produce a color change.
5.2 LOSS ON DRYING (731)
Analysis: Dry at 80° for 3 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed, light-resistant containers. Store at 25°, excursions permitted between 15° and 30°.
USP REFERENCE STANDARDS (11)
USP Metronidazole RS
USP Metronidazole Benzoate RS
USP Tinidazole Related Compound A RS
2-Methyl-5-nitroimidazole.
C4H5N3O2 127.10

